Does IDECABTAGENE VICLEUCEL Cause Myelosuppression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Myelosuppression have been filed in association with IDECABTAGENE VICLEUCEL (Abecma). This represents 0.5% of all adverse event reports for IDECABTAGENE VICLEUCEL.
5
Reports of Myelosuppression with IDECABTAGENE VICLEUCEL
0.5%
of all IDECABTAGENE VICLEUCEL reports
0
Deaths
3
Hospitalizations
How Dangerous Is Myelosuppression From IDECABTAGENE VICLEUCEL?
Of the 5 reports, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDECABTAGENE VICLEUCEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does IDECABTAGENE VICLEUCEL Cause?
Cytokine release syndrome (607)
Immune effector cell-associated neurotoxicity syndrome (176)
Fatigue (159)
Neurotoxicity (70)
Neutropenia (68)
Pyrexia (67)
Anaemia (63)
Decreased appetite (54)
Headache (54)
Hypogammaglobulinaemia (54)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which IDECABTAGENE VICLEUCEL Alternatives Have Lower Myelosuppression Risk?
IDECABTAGENE VICLEUCEL vs IDELALISIB
IDECABTAGENE VICLEUCEL vs IDURSULFASE
IDECABTAGENE VICLEUCEL vs IFOSFAMIDE
IDECABTAGENE VICLEUCEL vs IGURATIMOD
IDECABTAGENE VICLEUCEL vs ILOPERIDONE